<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04082169</url>
  </required_header>
  <id_info>
    <org_study_id>2018/1206</org_study_id>
    <nct_id>NCT04082169</nct_id>
  </id_info>
  <brief_title>Causes and Consequences of Primary Ovarian Insufficiency</brief_title>
  <acronym>Clinical POI</acronym>
  <official_title>Causes and Consequences of Primary Ovarian Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      100 women with primary ovarian insufficiency will be included for extensive diagnostic workup
      to improve diagnostic precision by extended autoantibody screening and genetic and
      toxicological testing.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Autoimmune</measure>
    <time_frame>one day</time_frame>
    <description>Prevalence of primary ovarian insufficiency (POI) with autoimmune etiology based on positive autoantibodies toward steroidogenic cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic</measure>
    <time_frame>one day</time_frame>
    <description>Prevalence of POI with genetic etiology defined by detection of genetic defects in a NGS panel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endocrine disrupting chemicals</measure>
    <time_frame>one day</time_frame>
    <description>Characterize the cohort of women with POI, including testing for environmental factors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phenotype description</measure>
    <time_frame>one day</time_frame>
    <description>Describe phenotypical characteristics including menstrual characteristics, hormone profile, BMD</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Primary Ovarian Insufficiency</condition>
  <condition>Premature Menopause</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        100 women with primary ovarian insufficiency defined as absence of menstruation more than 4
        months and serum level of follicle stimulation hormone (FSH) in menopausal range at 2 or
        more occations
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:Women 40 years or younger, more than 4 months amenorrhea, more than 2
        FSH measurements in menopausal range (drawn at least 2 months apart), ability to provide
        informed concent -

        Exclusion Criteria:History of oophorectomy, chemotherapy or radiation

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Ovarian insufficiency</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kahtan Al-Azawy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eystein Husebye, prof</last_name>
    <phone>+4755975000</phone>
    <email>eyhu@helse-bergen.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>HaukelandUH</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elinor Vogt, MD</last_name>
      <phone>+4793899380</phone>
      <email>elinor.vogt@uib.no</email>
    </contact>
    <investigator>
      <last_name>Marianne Oksnes, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 20, 2019</study_first_submitted>
  <study_first_submitted_qc>September 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2019</study_first_posted>
  <last_update_submitted>September 5, 2019</last_update_submitted>
  <last_update_submitted_qc>September 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
    <mesh_term>Menopause, Premature</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

